Cedars-Sinai Team Pioneers Liver Cancer Blood Test
Cedars-Sinai Cancer investigators have created a blood test that uses a technology to detect the most common form of liver cancer.
Read MorePosted by Andy Lundin | Sep 1, 2022 | Unknown Origin & Other Cancer Types |
Cedars-Sinai Cancer investigators have created a blood test that uses a technology to detect the most common form of liver cancer.
Read MorePosted by Andy Lundin | Aug 17, 2022 | Diabetes & Metabolic Diseases |
A new study estimates that the number of undiagnosed diabetes cases in the U.S. is significantly lower than current estimates suggest.
Read MorePosted by Andy Lundin | Jul 5, 2022 | Diabetes & Metabolic Diseases |
In a study led by MedUni Vienna, a new method has now been used to determine alcohol consumption in fatty liver disease.
Read MorePosted by Andy Lundin | Jun 23, 2022 | Unknown Origin & Other Cancer Types |
Researchers developed a blood test to predict which patients with nonalcoholic fatty liver disease are most likely to develop liver cancer.
Read MorePosted by Andy Lundin | Jun 16, 2022 | Diabetes & Metabolic Diseases |
A new test could more accurately predict if individuals who undergo gastric bypass surgery will experience a remission of type 2 diabetes.
Read More